This Article Full Text Full Text (PDF) All Versions of this Article: 50/2/289    most recent HYPERTENSIONAHA.107.092106v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Floras, J. S. Articles by Bradley, T. D. Search for Related Content PubMed PubMed Citation Articles by Floras, J. S. Articles by Bradley, T. D. Related Collections Contractile function Other heart failure Other hypertension Clinical Studies Other etiology Other Treatment Related Article

(Hypertension. 2007;50:289.)
© 2007 American Heart Association, Inc.

Editorial Commentaries

Treating Obstructive Sleep Apnea

Is There More to the Story Than 2 Millimeters of Mercury?

John S. Floras; T. Douglas Bradley

From the Department of Medicine (J.S.F., T.D.B.), University Health Network and Mount Sinai Hospital, Toronto, Ontario, Canada; Toronto Rehabilitation Institute (T.D.B.), Toronto, Ontario, Canada; and the University of Toronto (J.S.F., T.D.B.), Toronto, Ontario, Canada.

Correspondence to John S. Floras, Suite 1614, 600 University Ave, Toronto, Ontario M5G 1X5, Canada. E-mail john.floras@utoronto.ca

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Obstructive sleep apnea (OSA), a common disorder, increases the 4-year risk of developing hypertension by 3-fold.¹ In an uncontrolled trial, treatment of OSA when present in drug-resistant hypertension by nasal continuous positive airway pressure (CPAP) achieved substantial reductions in both nighttime and daytime blood pressure (BP).² However, in controlled and uncontrolled studies involving small cohorts of patients with OSA with stage 1 hypertension, prehypertension, or normal BP, the short-term use of CPAP had less or no effect on BP. A meta-analysis in the present issue of Hypertension³ attempts to estimate the effect of this intervention on BP.

The authors identified all of the published trials that reported BP as a primary or a secondary end point in which adults with OSA diagnosed by polysomnography were randomly allocated to therapeutic CPAP or not for 2 weeks. These 16 trials involved 818 participants (86.3% men; mean age: 51 years; mean apnea-hypopnea index: 36.2 events per hour) treated for 24 weeks. From the 15 trials that reported systolic and diastolic BP, the authors calculated a significant mean net reduction of 2.46/1.83 mm Hg with CPAP and, from the 7 trials that reported mean arterial BP, a significant net reduction of 2.22 mm Hg. By comparison, in a previous meta-analysis restricted to 12 trials in which the primary variable of interest was 24-hour mean ambulatory BP, the calculated net decrease was still significant at 1.69 mm Hg.⁴ In the present analysis by Bazzano et al,³ the mean net change in systolic BP tended to . . . [Full Text of this Article]

Related Article:

Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea

Lydia A. Bazzano, Zia Khan, Kristi Reynolds, and Jiang He
Hypertension 2007 50: 417-423. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				J S Floras Should sleep apnoea be a specific target of therapy in chronic heart failure? Heart, July 1, 2009; 95(13): 1041 - 1046. [Abstract] [Full Text] [PDF]

				J. S. Floras Hypertension, Sleep Apnea, and Atherosclerosis Hypertension, January 1, 2009; 53(1): 1 - 3. [Full Text] [PDF]

				G. Lorenzi-Filho and L. F. Drager Is the Cardiovascular System the Primary Target of Obstructive Sleep Apnea? Am. J. Respir. Crit. Care Med., November 1, 2008; 178(9): 892 - 893. [Full Text] [PDF]

				V. K. Somers, D. P. White, R. Amin, W. T. Abraham, F. Costa, A. Culebras, S. Daniels, J. S. Floras, C. E. Hunt, L. J. Olson, et al. Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health) Circulation, September 2, 2008; 118(10): 1080 - 1111. [Full Text] [PDF]

				V. K. Somers, D. P. White, R. Amin, W. T. Abraham, F. Costa, A. Culebras, S. Daniels, J. S. Floras, C. E. Hunt, L. J. Olson, et al. Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health) J. Am. Coll. Cardiol., August 19, 2008; 52(8): 686 - 717. [Full Text] [PDF]

				F. H. Sert Kuniyoshi, A. Garcia-Touchard, A. S. Gami, A. Romero-Corral, C. van der Walt, S. Pusalavidyasagar, T. Kara, S. M. Caples, G. S. Pressman, E. C. Vasquez, et al. Day-Night Variation of Acute Myocardial Infarction in Obstructive Sleep Apnea J. Am. Coll. Cardiol., July 29, 2008; 52(5): 343 - 346. [Abstract] [Full Text] [PDF]